Krebs Biochemicals & Industries Limited (BOM:524518)
India · Delayed Price · Currency is INR 59.25
+3.00 (5.33%)
At close: Feb 12, 2026
BOM:524518 Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Operating Revenue | 230.23 | 433.12 | 504.22 | 521.34 | 597.03 | 386.06 |
Other Revenue | - | - | - | - | - | 140.77 |
| 230.23 | 433.12 | 504.22 | 521.34 | 597.03 | 526.84 | |
Revenue Growth (YoY) | -53.19% | -14.10% | -3.29% | -12.68% | 13.32% | 62.63% |
Cost of Revenue | 53.35 | 100.31 | 93.99 | 277.16 | 441.18 | 515.96 |
Gross Profit | 176.89 | 332.81 | 410.23 | 244.19 | 155.85 | 10.87 |
Selling, General & Admin | 122.48 | 172.59 | 170.53 | 165.32 | 159.81 | 167.75 |
Other Operating Expenses | 153.51 | 306.24 | 323.98 | 231.74 | 328.01 | 12.6 |
Operating Expenses | 340.26 | 545.72 | 562.17 | 462.65 | 550.79 | 232.39 |
Operating Income | -163.37 | -212.91 | -151.95 | -218.46 | -394.94 | -221.52 |
Interest Expense | -67.85 | -59.08 | -46.86 | -29.71 | -53.85 | -62.72 |
Interest & Investment Income | 1.59 | 1.59 | 1.56 | 1.27 | 3.58 | 0.72 |
Other Non Operating Income (Expenses) | -0.06 | -0.06 | -0.04 | -0.02 | -0.06 | -0.07 |
EBT Excluding Unusual Items | -229.69 | -270.46 | -197.28 | -246.92 | -445.27 | -283.59 |
Gain (Loss) on Sale of Assets | 1.22 | 1.22 | - | - | - | - |
Pretax Income | -228.47 | -269.24 | -197.28 | -246.92 | -445.27 | -283.59 |
Income Tax Expense | 0.15 | 0.15 | - | - | - | - |
Net Income | -228.62 | -269.39 | -197.28 | -246.92 | -445.27 | -283.59 |
Net Income to Common | -228.62 | -269.39 | -197.28 | -246.92 | -445.27 | -283.59 |
Shares Outstanding (Basic) | 22 | 22 | 22 | 22 | 22 | 20 |
Shares Outstanding (Diluted) | 22 | 22 | 22 | 22 | 22 | 20 |
Shares Change (YoY) | -0.03% | - | - | - | 9.89% | 9.00% |
EPS (Basic) | -10.60 | -12.49 | -9.15 | -11.45 | -20.65 | -14.45 |
EPS (Diluted) | -10.60 | -12.49 | -9.15 | -11.45 | -20.65 | -14.45 |
Free Cash Flow | - | -114.54 | -70.5 | -398.71 | -442.95 | -400.81 |
Free Cash Flow Per Share | - | -5.31 | -3.27 | -18.49 | -20.54 | -20.43 |
Gross Margin | 76.83% | 76.84% | 81.36% | 46.84% | 26.11% | 2.06% |
Operating Margin | -70.96% | -49.16% | -30.14% | -41.90% | -66.15% | -42.05% |
Profit Margin | -99.30% | -62.20% | -39.13% | -47.36% | -74.58% | -53.83% |
Free Cash Flow Margin | - | -26.45% | -13.98% | -76.48% | -74.19% | -76.08% |
EBITDA | -98.9 | -147.86 | -86.12 | -154.71 | -338.36 | -172.88 |
EBITDA Margin | -42.96% | -34.14% | -17.08% | -29.68% | -56.67% | -32.81% |
D&A For EBITDA | 64.47 | 65.05 | 65.82 | 63.75 | 56.58 | 48.64 |
EBIT | -163.37 | -212.91 | -151.95 | -218.46 | -394.94 | -221.52 |
EBIT Margin | -70.96% | -49.16% | -30.14% | -41.90% | -66.15% | -42.05% |
Revenue as Reported | 233.84 | 440.21 | 508.73 | 527.55 | 608.59 | 543.22 |
Advertising Expenses | - | - | - | - | - | 0.05 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.